Like Causes?

Install the App
TRY NOW

senate Bill S. 771

Improving Access To Affordable Prescription Drugs Act

    Despite the terrific source of campaign donations that drug companies are, because their products are often life-saving there should be a humanitarian component to corporate decisionmaking about pricing. These companies do not, as they claim, funnel the majority of their profits into developing new, lifesaving drugs. Instead, they spend a huge amount on marketing. Don't believe me? Do some research. It's easy enough online. It's shameful that so many are reduced to taking non-theraputic doses of or giving up their needed medications because of cost. It's also ridiculous that we pay among the highest prices in the world for medication when other countries have capped what drug companies can charge. Yeah, I know, a free market should create competition that drives cost down. How does that happen when only a handful of campanies that own exclusive patents are the sole source? How's the free market really working in the airline, banking, cable, and cell phone industries with those very same conditions? Mergers and cooperative agreements have been the order of the day for awhile.
    Like
    Follow
    Share
    Proposed modification: To make this bill more effective, it should outlaw direct-to-consumer marketing of drugs. This would reduce development costs, and thereby reduce the cost to the consumer.
    Like
    Follow
    Share